Filing metadata

Accession number
0001209191-22-031705
Form type
Form 4
Filer
CRISPR Therapeutics AG
CIK
CIK 1674416
Filed
May 24, 2022
Reporting period
May 23, 2022
Description
Insider transaction

Explore SEC Filings Hub